MicroRNA-30a promotes intimal hyperplasia in arteriosclerosis obliterans by inducing endothelial-to-mesenchymal transition
王晗,李一男,王预立,张岚
DOI: https://doi.org/10.3760/cma.j.cn421213-20201010-00734
2021-01-01
Abstract:Objective:Vascular endothelial-to-mesenchymal transition (EndMT) may play an important role in atherogenesis. The detail mechanism of EndMT in the process of arteriosclerosis obliterans (ASO) is largely unknown. In this study, we aim to characterize the role of miR-30a-induced EndMT during atherogenesis.Methods:Hematoxylin-eosin (HE) staining was used to detect the tissue morphology and intima-media thickness of ASO diseased arteries. Immunofluorescence was used to detect the expression of endothelial biomarker CD31, mesenchymal biomarker α-smooth muscle actin (α-SMA) and EndMT associated transcription factor snail. Tumor necrosis factor-α (TNF-α) was used to induce EndMT in human umbilical vein endothelial cells (HUVECs). The miR-NC and miR-30a mimics were transfected into HUVECs as control and miR-30a groups, respectively. Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR) was used to detect the expression of miR-30a and mesenchymal biomarkers. RNA in situ hybridization was used to detect the expression of miR-30a in artery tissues. RT-qPCR and Western blotting were used to detect the change of epithelial and mesenchymal biomarkers induced by miR-30a overstressing. Cell proliferation and migration changes in miR-30a overexpressed HUVECs were measured by Cell Counting Kit-8 (CCK-8), wound healing and Transwell assays. T test was applied for statistical analysis using GraphPad Prism 7. Results:Down-regulation of CD31 and up-regulation of α-SMA accompanied with increased miR-30a were observed in ASO arterial intima and TNF-α-treated HUVECs [intimal thickness, CRTL=(178.40±29.61) μm, ASO=(422.10±39.47) μm, t=4.940, P<0.01, n=6; medial thickness, CRTL=(315.80±48.46) μm, ASO=(656.80±43.91) μm, t=5.200, P<0.01, n=6]. Overexpression of miR-30a induced the expression of mesenchymal biomarkers (CD31, CRTL=3.535±0.116, miR-30a=1.360±0.1846, t=9.966, P<0.01, n=3; VE-Cadherin, CRTL=2.453±0.075, miR-30a=0.793±0.106, t=12.830, P<0.01, n=3; α-SMA, CRTL=0.792±0.121, miR-30a=6.296±0.380, t=13.820, P<0.01, n=3; COL1, CRTL=0.241±0.063, miR-30a=2.859±0.142, t=16.840, P<0.01, n=3), and promoted proliferation and migration of HUVECs [cell migration rate, CTRL=(50.160±1.210)%, miR-30a=(68.560±1.918)%, t=8.115, P<0.01, n=6]. Conclusion:MiR-30a is significantly up-regulated through the intimal hyperplasia process of ASO. The miR-30a can promote EndMT of HUVECs and enhance its proliferation and migration, which in turn leads to the ASO intimal hyperplasia and contributes to the progression of ASO.